Macquarie Group LTD Baxter International Inc Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Baxter International Inc stock. As of the latest transaction made, Macquarie Group LTD holds 6,031,280 shares of BAX stock, worth $200 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

6,031,280

Previous 7,665,704 21.32%

Holding current value

$200 Million

Previous $256 Million 10.69%

% of portfolio

0.25%

Previous 0.3%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.85 - $40.26 $53.7 Million - $65.8 Million	-1,634,424 Reduced 21.32%	6,031,280 $229 Million
Q2 2024 Aug 09, 2024	SELL	$32.87 - $43.55 $3.12 Million - $4.14 Million	-95,017 Reduced 1.22%	7,665,704 $256 Million
Q1 2024 May 14, 2024	SELL	$37.88 - $43.77 $20.6 Million - $23.8 Million	-543,566 Reduced 6.55%	7,760,721 $332 Million
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $1.78 Million - $2.19 Million	-56,105 Reduced 0.67%	8,304,287 $321 Million
Q3 2023 Nov 14, 2023	SELL	$37.32 - $49.29 $10.5 Million - $13.9 Million	-282,062 Reduced 3.26%	8,360,392 $316 Million
Q2 2023 Aug 14, 2023	SELL	$39.98 - $47.68 $23.8 Million - $28.4 Million	-596,537 Reduced 6.46%	8,642,454 $394 Million
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $54.5 Million - $76.2 Million	1,449,983 Added 18.62%	9,238,991 $375 Million
Q4 2022 Feb 21, 2023	BUY	$49.7 - $57.71 $53.2 Million - $61.8 Million	1,070,426 Added 15.93%	7,789,008 $397 Million
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $8.95 Million - $11.1 Million	166,095 Added 2.53%	6,718,582 $362 Million
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $10 Million - $12.6 Million	157,024 Added 2.46%	6,552,487 $421 Million
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $21.5 Million - $25 Million	-279,729 Reduced 4.19%	6,395,463 $496 Million
Q4 2021 Feb 11, 2022	BUY	$74.57 - $87.19 $347 Million - $406 Million	4,651,034 Added 229.78%	6,675,192 $573 Million
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $147 Million - $167 Million	1,994,684 Added 6767.61%	2,024,158 $163 Million
Q2 2021 Aug 13, 2021	BUY	$80.5 - $88.01 $629,188 - $687,886	7,816 Added 36.09%	29,474 $2.37 Million
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $5.91 Million - $6.66 Million	-77,386 Reduced 78.13%	21,658 $1.83 Million
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $23,672 - $25,861	314 Added 0.32%	99,044 $7.95 Million
Q3 2020 Nov 13, 2020	SELL	$78.33 - $90.73 $8.22 Million - $9.52 Million	-104,965 Reduced 51.53%	98,730 $8.36 Million
Q2 2020 Aug 11, 2020	SELL	$78.66 - $94.14 $1.16 Million - $1.39 Million	-14,735 Reduced 6.75%	203,695 $17.5 Million
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $1.61 Million - $2.1 Million	-22,488 Reduced 9.33%	218,430 $17.7 Million
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $17.2 Million - $19.8 Million	224,169 Added 1338.4%	240,918 $20.1 Million
Q2 2019 Aug 14, 2019	BUY	$73.44 - $82.41 $163,036 - $182,950	2,220 Added 15.28%	16,749 $1.37 Million
Q1 2019 May 15, 2019	BUY	$64.48 - $81.31 $297,188 - $374,757	4,609 Added 46.46%	14,529 $1.18 Million
Q3 2018 Nov 15, 2018	SELL	$70.71 - $77.75 $147,076 - $161,720	-2,080 Reduced 17.33%	9,920 $764,000
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $50,744 - $60,328	-800 Reduced 6.25%	12,000 $886,000
Q1 2018 May 11, 2018	SELL	$62.56 - $72.26 $106,352 - $122,842	-1,700 Reduced 11.72%	12,800 $833,000
Q4 2017 Feb 15, 2018	SELL	$61.45 - $66.05 $497,745 - $535,005	-8,100 Reduced 35.84%	14,500 $1.06 Million
Q3 2017 Nov 08, 2017	BUY	$59.5 - $64.61 $1.34 Million - $1.46 Million	22,600	22,600 $1.42 Million

Others Institutions Holding BAX

# of Institutions

1,006

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Baxter International Inc Transaction History